Table of Content

1 Report Overview
1.1 Tourette Syndrome Drug Definition
1.2 Market by Type
1.2.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Tourette Syndrome Drug Sales
2.1 Global Tourette Syndrome Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Tourette Syndrome Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Tourette Syndrome Drug Revenue by Region
2.3.1 Global Tourette Syndrome Drug Revenue by Region (2018-2023)
2.3.2 Global Tourette Syndrome Drug Revenue by Region (2024-2034)
2.4 Global Tourette Syndrome Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Tourette Syndrome Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Tourette Syndrome Drug Sales Quantity by Region
2.6.1 Global Tourette Syndrome Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Tourette Syndrome Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Tourette Syndrome Drug Sales Quantity by Manufacturers
3.1.1 Global Tourette Syndrome Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Tourette Syndrome Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Sales in 2024
3.2 Global Tourette Syndrome Drug Revenue by Manufacturers
3.2.1 Global Tourette Syndrome Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Tourette Syndrome Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2024
3.3 Global Tourette Syndrome Drug Sales Price by Manufacturers
3.4 Global Key Players of Tourette Syndrome Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tourette Syndrome Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tourette Syndrome Drug, Product Offered and Application
3.8 Global Key Manufacturers of Tourette Syndrome Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Tourette Syndrome Drug Sales Quantity by Type
4.1.1 Global Tourette Syndrome Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Tourette Syndrome Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Tourette Syndrome Drug Revenue by Type
4.2.1 Global Tourette Syndrome Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Tourette Syndrome Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
4.3 Global Tourette Syndrome Drug Price by Type
4.3.1 Global Tourette Syndrome Drug Price by Type (2018-2023)
4.3.2 Global Tourette Syndrome Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Tourette Syndrome Drug Sales Quantity by Application
5.1.1 Global Tourette Syndrome Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Tourette Syndrome Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Tourette Syndrome Drug Revenue by Application
5.2.1 Global Tourette Syndrome Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Tourette Syndrome Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
5.3 Global Tourette Syndrome Drug Price by Application
5.3.1 Global Tourette Syndrome Drug Price by Application (2018-2023)
5.3.2 Global Tourette Syndrome Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Tourette Syndrome Drug Sales by Company
6.1.1 North America Tourette Syndrome Drug Revenue by Company (2018-2023)
6.1.2 North America Tourette Syndrome Drug Sales Quantity by Company (2018-2023)
6.2 North America Tourette Syndrome Drug Market Size by Type
6.2.1 North America Tourette Syndrome Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Tourette Syndrome Drug Revenue by Type (2018-2034)
6.3 North America Tourette Syndrome Drug Market Size by Application
6.3.1 North America Tourette Syndrome Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Tourette Syndrome Drug Revenue by Application (2018-2034)
6.4 North America Tourette Syndrome Drug Market Size by Country
6.4.1 North America Tourette Syndrome Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Tourette Syndrome Drug Revenue by Country (2018-2034)
6.4.3 North America Tourette Syndrome Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Tourette Syndrome Drug Sales by Company
7.1.1 Europe Tourette Syndrome Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Tourette Syndrome Drug Revenue by Company (2018-2023)
7.2 Europe Tourette Syndrome Drug Market Size by Type
7.2.1 Europe Tourette Syndrome Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Tourette Syndrome Drug Revenue by Type (2018-2034)
7.3 Europe Tourette Syndrome Drug Market Size by Application
7.3.1 Europe Tourette Syndrome Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Tourette Syndrome Drug Revenue by Application (2018-2034)
7.4 Europe Tourette Syndrome Drug Market Size by Country
7.4.1 Europe Tourette Syndrome Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Tourette Syndrome Drug Revenue by Country (2018-2034)
7.4.3 Europe Tourette Syndrome Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Tourette Syndrome Drug Sales by Company
8.1.1 China Tourette Syndrome Drug Sales Quantity by Company (2018-2023)
8.1.2 China Tourette Syndrome Drug Revenue by Company (2018-2023)
8.2 China Tourette Syndrome Drug Market Size by Type
8.2.1 China Tourette Syndrome Drug Sales Quantity by Type (2018-2034)
8.2.2 China Tourette Syndrome Drug Revenue by Type (2018-2034)
8.3 China Tourette Syndrome Drug Market Size by Application
8.3.1 China Tourette Syndrome Drug Sales Quantity by Application (2018-2034)
8.3.2 China Tourette Syndrome Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Tourette Syndrome Drug Sales by Company
9.1.1 APAC Tourette Syndrome Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Tourette Syndrome Drug Revenue by Company (2018-2023)
9.2 APAC Tourette Syndrome Drug Market Size by Type
9.2.1 APAC Tourette Syndrome Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Tourette Syndrome Drug Revenue by Type (2018-2034)
9.3 APAC Tourette Syndrome Drug Market Size by Application
9.3.1 APAC Tourette Syndrome Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Tourette Syndrome Drug Revenue by Application (2018-2034)
9.4 APAC Tourette Syndrome Drug Market Size by Region
9.4.1 APAC Tourette Syndrome Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Tourette Syndrome Drug Revenue by Region (2018-2034)
9.4.3 APAC Tourette Syndrome Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tourette Syndrome Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Tourette Syndrome Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Tourette Syndrome Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Tourette Syndrome Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Abide Therapeutics Inc
11.1.1 Abide Therapeutics Inc Company Information
11.1.2 Abide Therapeutics Inc Overview
11.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products and Services
11.1.5 Abide Therapeutics Inc Tourette Syndrome Drug SWOT Analysis
11.1.6 Abide Therapeutics Inc Recent Developments
11.2 Catalyst Pharmaceuticals Inc
11.2.1 Catalyst Pharmaceuticals Inc Company Information
11.2.2 Catalyst Pharmaceuticals Inc Overview
11.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products and Services
11.2.5 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug SWOT Analysis
11.2.6 Catalyst Pharmaceuticals Inc Recent Developments
11.3 Neurocrine Biosciences Inc
11.3.1 Neurocrine Biosciences Inc Company Information
11.3.2 Neurocrine Biosciences Inc Overview
11.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products and Services
11.3.5 Neurocrine Biosciences Inc Tourette Syndrome Drug SWOT Analysis
11.3.6 Neurocrine Biosciences Inc Recent Developments
11.4 Psyadon Pharmaceuticals Inc
11.4.1 Psyadon Pharmaceuticals Inc Company Information
11.4.2 Psyadon Pharmaceuticals Inc Overview
11.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products and Services
11.4.5 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug SWOT Analysis
11.4.6 Psyadon Pharmaceuticals Inc Recent Developments
11.5 Reviva Pharmaceuticals Inc
11.5.1 Reviva Pharmaceuticals Inc Company Information
11.5.2 Reviva Pharmaceuticals Inc Overview
11.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products and Services
11.5.5 Reviva Pharmaceuticals Inc Tourette Syndrome Drug SWOT Analysis
11.5.6 Reviva Pharmaceuticals Inc Recent Developments
11.6 Synchroneuron Inc
11.6.1 Synchroneuron Inc Company Information
11.6.2 Synchroneuron Inc Overview
11.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Synchroneuron Inc Tourette Syndrome Drug Products and Services
11.6.5 Synchroneuron Inc Tourette Syndrome Drug SWOT Analysis
11.6.6 Synchroneuron Inc Recent Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Information
11.7.2 Teva Pharmaceutical Industries Ltd Overview
11.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products and Services
11.7.5 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug SWOT Analysis
11.7.6 Teva Pharmaceutical Industries Ltd Recent Developments
11.8 Therapix Biosciences Ltd
11.8.1 Therapix Biosciences Ltd Company Information
11.8.2 Therapix Biosciences Ltd Overview
11.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products and Services
11.8.5 Therapix Biosciences Ltd Tourette Syndrome Drug SWOT Analysis
11.8.6 Therapix Biosciences Ltd Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Tourette Syndrome Drug Value Chain Analysis
12.2 Tourette Syndrome Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tourette Syndrome Drug Production Mode & Process
12.4 Tourette Syndrome Drug Sales and Marketing
12.4.1 Tourette Syndrome Drug Sales Channels
12.4.2 Tourette Syndrome Drug Distributors
12.5 Tourette Syndrome Drug Customers
13 Market Dynamics
13.1 Tourette Syndrome Drug Industry Trends
13.2 Tourette Syndrome Drug Market Drivers
13.3 Tourette Syndrome Drug Market Challenges
13.4 Tourette Syndrome Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AZD-5213
Table 3. Major Manufacturers of CPP-115
Table 4. Major Manufacturers of Dutetrabenazine ER
Table 5. Major Manufacturers of Ecopipam Hydrochloride
Table 6. Major Manufacturers of Others
Table 7. Global Tourette Syndrome Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Tourette Syndrome Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Tourette Syndrome Drug Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Tourette Syndrome Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Tourette Syndrome Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Tourette Syndrome Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Tourette Syndrome Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Tourette Syndrome Drug Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Tourette Syndrome Drug Sales Market Share by Region (2018-2023)
Table 16. Global Tourette Syndrome Drug Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Tourette Syndrome Drug Sales Market Share by Region (2024-2034)
Table 18. Global Tourette Syndrome Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Tourette Syndrome Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Tourette Syndrome Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Tourette Syndrome Drug Revenue Share by Manufacturers (2018-2023)
Table 22. Global Tourette Syndrome Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Tourette Syndrome Drug, Industry Ranking, 2021 VS 2024
Table 24. Global Tourette Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tourette Syndrome Drug as of 2024)
Table 26. Global Key Manufacturers of Tourette Syndrome Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Tourette Syndrome Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Tourette Syndrome Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Tourette Syndrome Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Tourette Syndrome Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Tourette Syndrome Drug Sales Quantity Share by Type (2018-2023)
Table 33. Global Tourette Syndrome Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Tourette Syndrome Drug Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Tourette Syndrome Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Tourette Syndrome Drug Revenue Share by Type (2018-2023)
Table 37. Global Tourette Syndrome Drug Revenue Share by Type (2024-2034)
Table 38. Tourette Syndrome Drug Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Tourette Syndrome Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Tourette Syndrome Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Tourette Syndrome Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Tourette Syndrome Drug Sales Quantity Share by Application (2018-2023)
Table 43. Global Tourette Syndrome Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Tourette Syndrome Drug Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Tourette Syndrome Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Tourette Syndrome Drug Revenue Share by Application (2018-2023)
Table 47. Global Tourette Syndrome Drug Revenue Share by Application (2024-2034)
Table 48. Tourette Syndrome Drug Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Tourette Syndrome Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Tourette Syndrome Drug Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Tourette Syndrome Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Tourette Syndrome Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Tourette Syndrome Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Tourette Syndrome Drug Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Tourette Syndrome Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Tourette Syndrome Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Tourette Syndrome Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Tourette Syndrome Drug Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Tourette Syndrome Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Tourette Syndrome Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Tourette Syndrome Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Tourette Syndrome Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Tourette Syndrome Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Tourette Syndrome Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Tourette Syndrome Drug Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Tourette Syndrome Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Tourette Syndrome Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Tourette Syndrome Drug Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Tourette Syndrome Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Tourette Syndrome Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Tourette Syndrome Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Tourette Syndrome Drug Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Tourette Syndrome Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Tourette Syndrome Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Tourette Syndrome Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Tourette Syndrome Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Tourette Syndrome Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Tourette Syndrome Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Tourette Syndrome Drug Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Tourette Syndrome Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Tourette Syndrome Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Tourette Syndrome Drug Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Tourette Syndrome Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Tourette Syndrome Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Tourette Syndrome Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Tourette Syndrome Drug Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Tourette Syndrome Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Tourette Syndrome Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Tourette Syndrome Drug Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Tourette Syndrome Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Tourette Syndrome Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Tourette Syndrome Drug Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Tourette Syndrome Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Tourette Syndrome Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Tourette Syndrome Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Tourette Syndrome Drug Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Tourette Syndrome Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Tourette Syndrome Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Tourette Syndrome Drug Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Tourette Syndrome Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Tourette Syndrome Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Tourette Syndrome Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Abide Therapeutics Inc Company Information
Table 121. Abide Therapeutics Inc Description and Overview
Table 122. Abide Therapeutics Inc Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Abide Therapeutics Inc Tourette Syndrome Drug Product and Services
Table 124. Abide Therapeutics Inc Tourette Syndrome Drug SWOT Analysis
Table 125. Abide Therapeutics Inc Recent Developments
Table 126. Catalyst Pharmaceuticals Inc Company Information
Table 127. Catalyst Pharmaceuticals Inc Description and Overview
Table 128. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
Table 130. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug SWOT Analysis
Table 131. Catalyst Pharmaceuticals Inc Recent Developments
Table 132. Neurocrine Biosciences Inc Company Information
Table 133. Neurocrine Biosciences Inc Description and Overview
Table 134. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Neurocrine Biosciences Inc Tourette Syndrome Drug Product and Services
Table 136. Neurocrine Biosciences Inc Tourette Syndrome Drug SWOT Analysis
Table 137. Neurocrine Biosciences Inc Recent Developments
Table 138. Psyadon Pharmaceuticals Inc Company Information
Table 139. Psyadon Pharmaceuticals Inc Description and Overview
Table 140. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
Table 142. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug SWOT Analysis
Table 143. Psyadon Pharmaceuticals Inc Recent Developments
Table 144. Reviva Pharmaceuticals Inc Company Information
Table 145. Reviva Pharmaceuticals Inc Description and Overview
Table 146. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product and Services
Table 148. Reviva Pharmaceuticals Inc Tourette Syndrome Drug SWOT Analysis
Table 149. Reviva Pharmaceuticals Inc Recent Developments
Table 150. Synchroneuron Inc Company Information
Table 151. Synchroneuron Inc Description and Overview
Table 152. Synchroneuron Inc Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Synchroneuron Inc Tourette Syndrome Drug Product and Services
Table 154. Synchroneuron Inc Tourette Syndrome Drug SWOT Analysis
Table 155. Synchroneuron Inc Recent Developments
Table 156. Teva Pharmaceutical Industries Ltd Company Information
Table 157. Teva Pharmaceutical Industries Ltd Description and Overview
Table 158. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product and Services
Table 160. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug SWOT Analysis
Table 161. Teva Pharmaceutical Industries Ltd Recent Developments
Table 162. Therapix Biosciences Ltd Company Information
Table 163. Therapix Biosciences Ltd Description and Overview
Table 164. Therapix Biosciences Ltd Tourette Syndrome Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 165. Therapix Biosciences Ltd Tourette Syndrome Drug Product and Services
Table 166. Therapix Biosciences Ltd Tourette Syndrome Drug SWOT Analysis
Table 167. Therapix Biosciences Ltd Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Tourette Syndrome Drug Distributors List
Table 171. Tourette Syndrome Drug Customers List
Table 172. Tourette Syndrome Drug Market Trends
Table 173. Tourette Syndrome Drug Market Drivers
Table 174. Tourette Syndrome Drug Market Challenges
Table 175. Tourette Syndrome Drug Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Tourette Syndrome Drug Product Picture
Figure 2. Global Tourette Syndrome Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Tourette Syndrome Drug Market Share by Type in 2024 & 2034
Figure 4. AZD-5213 Product Picture
Figure 5. CPP-115 Product Picture
Figure 6. Dutetrabenazine ER Product Picture
Figure 7. Ecopipam Hydrochloride Product Picture
Figure 8. Others Product Picture
Figure 9. Global Tourette Syndrome Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Tourette Syndrome Drug Market Share by Application in 2024 & 2034
Figure 11. Research Center
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Tourette Syndrome Drug Report Years Considered
Figure 16. Global Tourette Syndrome Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Tourette Syndrome Drug Revenue 2018-2034 (US$ Million)
Figure 18. Global Tourette Syndrome Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Tourette Syndrome Drug Sales Quantity 2018-2034 (K Pcs)
Figure 20. Global Tourette Syndrome Drug Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Tourette Syndrome Drug Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Tourette Syndrome Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. North America Tourette Syndrome Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Tourette Syndrome Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. Europe Tourette Syndrome Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Tourette Syndrome Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. China Tourette Syndrome Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Tourette Syndrome Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. APAC Tourette Syndrome Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Tourette Syndrome Drug Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Tourette Syndrome Drug Revenue in 2024
Figure 34. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
Figure 37. Global Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
Figure 39. North America Tourette Syndrome Drug Revenue Market Share by Company in 2024
Figure 40. North America Tourette Syndrome Drug Sales Quantity Market Share by Company in 2024
Figure 41. North America Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
Figure 43. North America Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
Figure 45. North America Tourette Syndrome Drug Revenue Share by Country (2018-2034)
Figure 46. North America Tourette Syndrome Drug Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Tourette Syndrome Drug Sales Quantity Market Share by Company in 2024
Figure 50. Europe Tourette Syndrome Drug Revenue Market Share by Company in 2024
Figure 51. Europe Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
Figure 53. Europe Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
Figure 55. Europe Tourette Syndrome Drug Revenue Share by Country (2018-2034)
Figure 56. Europe Tourette Syndrome Drug Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 58. France Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 62. China Tourette Syndrome Drug Sales Quantity Market Share by Company in 2024
Figure 63. China Tourette Syndrome Drug Revenue Market Share by Company in 2024
Figure 64. China Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
Figure 66. China Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
Figure 68. APAC Tourette Syndrome Drug Sales Quantity Market Share by Company in 2024
Figure 69. APAC Tourette Syndrome Drug Revenue Market Share by Company in 2024
Figure 70. APAC Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
Figure 72. APAC Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
Figure 74. APAC Tourette Syndrome Drug Revenue Share by Region (2018-2034)
Figure 75. APAC Tourette Syndrome Drug Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 80. India Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Tourette Syndrome Drug Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Tourette Syndrome Drug Revenue Share by Country (2018-2034)
Figure 89. Brazil Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Tourette Syndrome Drug Revenue (2018-2034) & (US$ Million)
Figure 94. Tourette Syndrome Drug Value Chain
Figure 95. Tourette Syndrome Drug Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed